Showing results (1061-1070 of 1,240) with videos related to
Sort By:
Pageof 124
The Journal of Clinical Investigation|February 12, 1998
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion proteinV Karanikas, L A Hwang, J Pearson, et al.Health Technology Assessment (Winchester, England)|January 30, 2013
A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapyC Salisbury, N E Foster, C Hopper, et al.The Canadian Journal of Cardiology|November 26, 2013
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus updateG B John Mancini, A Yashar Tashakkor, Steven Baker, et al.European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumoursDidier Frappaz, Sara M Federico, Andrew D J Pearson, et al.Calcified Tissue International|March 1, 1996
Radial cortical and trabecular bone densities of men and women standardized with the European Forearm PhantomJ Reeve, H Kröger, J Nijs, et al.DNA Repair|May 15, 2007
Alkyltransferase-like proteinsGeoffrey P Margison, Amna Butt, Steven J Pearson, et al.Oncogene|December 12, 2018
ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transitionScott J Pearson, Tapasree Roy Sarkar, Cole M McQueen, et al.Pediatric Blood & Cancer|May 6, 2006
A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancerM Cole, L Price, A Parry, et al.Science Advances|February 23, 2019
Charge extraction via graded doping of hole transport layers gives highly luminescent and stable metal halide perovskite devicesMojtaba Abdi-Jalebi, M Ibrahim Dar, Satyaprasad P Senanayak, et al.Cancer Research and Treatment|March 22, 2017
Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN StudyLoredana Amoroso, Giovanni Erminio, Guy Makin, et al.Pageof 124